HIT Consultant November 10, 2021
What You Should Know:
– CareDx, Inc. (Nasdaq: CDNA), a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has acquired MedActionPlan®, a New Jersey-based provider of medication safety and adherence technology and patient education.
– MedActionPlan programs have been proven to improve adherence, reduce healthcare costs, and increase patient satisfaction.
Acquisition Benefits for CareDx
The acquisition complements CareDx’s goal of connecting offerings for transplant patients, including:
– MedActionPlan PRO: a medication management and adherence platform to simplify post-transplant medication regimens. It is used by more than 100 healthcare systems, with the majority being...
Today's Sponsors
Today's Sponsor